Beaird Harris Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Beaird Harris Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3K	Hold	6	–	–	﹤0.01%	482
2026 Q1	$3.52K	Hold	6	–	–	﹤0.01%	444
2025 Q4	$4.24K	Hold	6	–	–	﹤0.01%	451
2025 Q3	$4K	Buy	6 +1	+20%	+$607	﹤0.01%	444
2025 Q2	$2.68K	Hold	5	–	–	﹤0.01%	472
2025 Q1	$2.1K	Hold	5	–	–	﹤0.01%	437
2024 Q4	$2.07K	Hold	5	–	–	﹤0.01%	435
2024 Q3	$2.53K	Sell	5 -8	-62%	-$3.89K	﹤0.01%	415
2024 Q2	$6.33K	Buy	13 +5	+63%	+$2.51K	﹤0.01%	425
2024 Q1	$4.32K	Sell	8 -8	-50%	-$4.37K	﹤0.01%	406
2023 Q4	$8.88K	Buy	+16	New	+$7.51K	﹤0.01%	332

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Beaird Harris Wealth Management's IDXX Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 6 shares worth $3.3K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Beaird Harris Wealth Management first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.88K in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Beaird Harris Wealth Management held 6 shares of Idexx Laboratories worth $3.3K as of Q2 2026.
Beaird Harris Wealth Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #482 holding.
Beaird Harris Wealth Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
Beaird Harris Wealth Management's Idexx Laboratories position peaked at $8.88K in Q4 2023.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.